A nurse is reinforcing teaching with a parent of a child who has a new prescription for a budesonide inhaler. Which of the following adverse reactions should the nurse include in the teaching?

Rationale for Correct Choices:

• Ceftriaxone: The infant has a documented allergy to amoxicillin, and ceftriaxone is a cephalosporin antibiotic that has potential cross-reactivity with amoxicillin. Therefore, the nurse should clarify the prescription for ceftriaxone to ensure it’s safe for the infant.
• Allergy: The infant’s known allergy to amoxicillin suggests a potential allergy to ceftriaxone as well. Given the risk of anaphylaxis or other allergic reactions, the nurse must clarify the use of ceftriaxone with the healthcare provider.

Rationale for Incorrect Choices:

• Furosemide: Furosemide is a diuretic used to manage fluid retention, especially in conditions like heart failure or VSD. There are no contraindications based on the infant's current findings, such as the heart rate, medical history, or electrolyte values.
• Digoxin: Digoxin is used to help regulate heart function in infants with conditions like VSD. The infant's heart rate of 84/min is within an acceptable range for digoxin administration.
• Acetaminophen: Acetaminophen is used to manage the infant’s fever (39.2°C). Given that the infant’s temperature is elevated, acetaminophen is appropriate for fever reduction and does not require clarification.
• Ibuprofen: Ibuprofen could also be used for fever management, no immediate concerns require clarification for ibuprofen. The nurse should monitor the infant closely for any side effects, but it doesn't necessitate clarification.

• Diet: The infant's diet is not directly related to the concern about ceftriaxone administration. The infant is being fed via gastrostomy tube, and while this is a consideration for medication administration, it does not specifically affect the need to clarify ceftriaxone due to an allergy.
• Temperature: The infant’s temperature of 39.2°C indicates fever, but it is not directly related to the need to clarify the ceftriaxone prescription.
• Heart rate: The infant’s heart rate is within an acceptable range for digoxin administration (84/min), and there’s no concern regarding bradycardia or tachycardia that would require clarifying the prescription for digoxin.
• Medical history: While the infant has Down syndrome and a ventricular septal defect (VSD), which require ongoing care, the focus here is on the allergy to amoxicillin, which is directly relevant to the ceftriaxone prescription.

Rationale for Correct Choices:

• Lead poisoning: The child's exposure to construction dust in a home built in the 1950s, coupled with symptoms like lethargy, irritability, weakness, and abdominal discomfort, suggests lead poisoning. Lead exposure in older homes with construction dust is a significant risk factor.
• Reinforce education on lead exposure and prevention: Given the suspected lead exposure, educating the parents about how to reduce the child’s exposure to lead is crucial. This includes steps like avoiding dust, cleaning thoroughly, and taking preventive measures to protect the child.
• Prepare to assist with chelation therapy: If lead poisoning is confirmed, chelation therapy is the mainstay treatment to help remove lead from the body. Chelation agents bind to lead in the body, facilitating its excretion.
• Blood lead levels: Monitoring blood lead levels is essential for confirming lead poisoning and determining the severity of the exposure. Elevated blood lead levels would guide the need for chelation therapy.
• Developmental milestones: Lead poisoning can adversely affect cognitive, motor, and developmental growth in children. Monitoring developmental milestones is critical to assess if lead exposure is impacting the child’s growth and development.

Rationale for Incorrect Choices:

• Meningitis: Although the child has had exposure to meningitis, the clinical presentation does not align with typical meningitis, which often presents with more acute symptoms like fever, nuchal rigidity, and altered consciousness.
• Guillain-Barré Syndrome: Guillain-Barré syndrome is unlikely as it typically presents with ascending paralysis. The child’s symptoms, such as irritability and weakness, are more consistent with lead poisoning, especially with the known risk factors of lead exposure.
• Diabetes mellitus type 1: While the child shows increased thirst and urination, the overall presentation of irritability, abdominal discomfort, and weakness, along with the known risk of lead exposure, makes lead poisoning a more likely diagnosis.
• Assist with lumbar puncture: A lumbar puncture is typically performed to diagnose meningitis or other central nervous system infections. The child’s symptoms do not suggest meningitis, and this action is not warranted at this time.
• Glycosylated hemoglobin (HbA1c): Monitoring HbA1c is useful for diagnosing diabetes, but it is not appropriate for assessing lead poisoning. Blood glucose levels would be more relevant to diagnose diabetes type 1, but in this case, lead poisoning is the primary concern.
• Assist with administration of intravenous immunoglobulin: Intravenous immunoglobulin (IVIG) is generally used to treat autoimmune disorders or infections, such as Guillain-Barré syndrome. It is not appropriate for lead poisoning, which requires chelation therapy.
• Nuchal rigidity: There is no indication of neck stiffness or signs of meningitis. Nuchal rigidity would be relevant in the case of suspected meningitis, but this is not the primary diagnosis here. The child’s symptoms align more with lead poisoning.
• Electromyography results: Electromyography is typically used to assess nerve function in conditions like Guillain-Barré syndrome, but it’s not necessary for diagnosing or managing lead poisoning.
• Obtain a serum blood glucose: While obtaining a blood glucose is important to rule out diabetes type 1, the child’s symptoms, coupled with the lead exposure risk, are more aligned with lead poisoning.